Stock Screener: Medical , Medical-Drugs

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Drugs belongs to the sector Medical. This industry has a Market Cap of 313.87B. The top rated companies for Medical-Drugs industry are: Shire (SHPG) , Takeda Pharma (TKPYY) , Astellas Pharma (ALPMY).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
United Therapeutics (UTHR)
4.6/5 6.51B 10.29 1.58% 17.89%
SciClone Pharma (SCLN)
4.4/5 528.41M 14.86 -1.42% 27.29%
Taro Pharma (TARO)
4.4/5 4.16B 7.89 -4.63% -32.58%
BioSpecifics Technologies (BSTC)
4.1/5 365.43M 33.85 -3.94% 35.25%
Jazz Pharma (JAZZ)
4.1/5 7.45B 21.66 5.61% -6.73%
USANA Health Sciences (USNA)
4.0/5 1.5B 15.78 0 -1.56
Sucampo Pharma (SCMP)
3.9/5 524.83M 38.00 -8.8% -16.54%
Enanta Pharma (ENTA)
3.8/5 625.27M 28.77 -5.21% 10.19%
Nutraceutical International (NUTR)
3.7/5 316.62M 17.40 -3.73% 48.72%
Xencor (XNCR)
3.6/5 1.04B 22.65 -16.9% 77.61%
Lannett Co (LCI)
3.4/5 713.47M - -4.93% -46.98%
Shire (SHPG)
3.4/5 49.45B 105.01 -5% -11.28%
Zoetis (ZTS)
3.3/5 26.42B 39.11 0.43% 24.35%
Corcept Therapeutics (CORT)
3.3/5 843.84M 185.00 -9.42% 93.72%
Nature's Sunshine Products (NATR)
3.3/5 237.24M 19.24 -2.31% 39.71%
AVADEL PHARMA (AVDL)
3.0/5 408.7M 17.78 3% -0.96%
Grifols (GRFS)
2.9/5 11.57B - -0.12% 12.84%
Valeant (VRX)
2.9/5 5.18B - -3.91% -83.37%
Depomed (DEPO)
2.9/5 1.11B - -5.77% 6.78%
Catalent (CTLT)
2.9/5 3.24B 31.96 -0.46% 10.45%
Endo International (ENDP)
2.6/5 2.88B - -6.44% -78.92%
Pacira Pharma (PCRX)
2.5/5 1.53B - 1.01% -39.25%
Ariad Pharma (ARIA)
2.4/5 4.61B - 0.25% 331.82%
Ionis Pharma (IONS)
2.3/5 5.66B - -2.33% 3.3%
Ironwood Pharma (IRWD)
2.3/5 2.16B - -5.74% 49.65%
Foamix (FOMX)
2.3/5 374.41M - -4.04% 41.61%
Fibrogen (FGEN)
2.2/5 1.55B - 0.39% 22.37%
Nektar Therapeutics (NKTR)
2.2/5 1.87B - -7.04% -18.56%
Aratana Therapeutics (PETX)
2.1/5 279.31M - -4.99% 142.68%
Zogenix (ZGNX)
2.1/5 230.56M - -13.53% -18.19%
AcelRx Pharma (ACRX)
2.0/5 122.4M - -7.02% -13.96%
Theravance Biopharma (TBPH)
2.0/5 1.62B - -5.97% 91.54%
Spectrum Pharma (SPPI)
2.0/5 370.57M - -1.18% -11.46%
Egalet (EGLT)
2.0/5 131.99M - -14.92% -40.87%
Immune Design (IMDZ)
1.9/5 135.94M - -12.8% -55.58%
Ocular Therapeutix (OCUL)
1.9/5 203.02M - -1.98% 9.68%
Aralez Pharma (ARLZ)
1.9/5 265.63M - 0.69% -32.2%
MediWound (MDWD)
1.9/5 113.73M - -2.83% -30.97%
Advanced Accelerator Applications (AAAP)
1.8/5 1.12B - -1.77% 2.58%
BioCryst Pharma (BCRX)
1.8/5 445.5M - -4.8% -19.59%
Durect (DRRX)
1.7/5 170.46M - -7.09% -9.23%
PTC Therapeutics (PTCT)
1.7/5 498.3M - -6.72% -47.62%
Concert Pharma (CNCE)
1.7/5 197.13M - -10.51% -41.69%
Portola Pharma (PTLA)
1.7/5 1.44B - -1.31% -32.82%
Bellicum (BLCM)
1.7/5 343.7M - -8.93% 0.16%
Corbus Pharmaceuticals (CRBP)
1.5/5 311.07M - -8% 360%
Cempra (CEMP)
1.5/5 167.62M - -11.76% -84.79%
Regulus Therapeutics (RGLS)
1.5/5 124.37M - -4.08% -63.51%
ImmunoGen (IMGN)
1.4/5 216.51M - 0 -75.2
CTI BioPharma (CTIC)
1.4/5 143.12M - -11.88% -57.16%
Achaogen (AKAO) 1.4/5 658.01M - -2.28% 301.6%
Rigel Pharma (RIGL)
1.4/5 222.61M - -12.35% -18.82%
ChemoCentryx (CCXI)
1.4/5 376.71M - -4.79% 83.05%
Neurocrine Biosciences (NBIX)
1.4/5 3.62B - -2.32% -18.07%
La Jolla Pharma (LJPC)
1.3/5 363.8M - -8.04% 17.51%
Tetraphase Pharmaceuticals (TTPH)
1.3/5 154.42M - -8.95% -31.83%
Karyopharm Therapeutics (KPTI)
1.2/5 431.81M - 2.67% 48.43%
Ardelyx (ARDX)
1.2/5 657.5M - -8.84% 14.04%
GlycoMimetics (GLYC) 1.1/5 133.32M - -6.53% 13.47%
MADRIGAL PHARMA (MDGL) 0.9/5 181.88M - -1.68% 85.95%
Heron Therapeutics (HRTX)
0.9/5 542.75M - 3.1% -42.84%
Generex Biotech (GNBT) - 4.36M - -16.67 0
Innate Pharma (IPHYF) - 788.79M - -8.14% 10.21%
China BCT (CNBI) - 0.3M - 14.29 0
American Oriental Bioengineering (AOBI) - 0.37M - 0 66.67
Elite Pharma (ELTP) - 160.21M - 10.63% -49.72%
Kun Run Biotech (KURU) - 0.63M - 0 -90
Dermira (DERM) - 1.04B - -6.91% -0.39%
INSPYR THERPTCS (NSPX) - 0.99M - 3.95% -82.46%
Synovics Pharma (SYVC) - 0M - 0 0
Osteologix (OLGXF) - 0.03M - 0 -85.71
Pharmathene (PIP) - 199.63M 1.89 -2.94% 91.86%
TherapeuticsMD (TXMD) - 1.1B - -6.19% -30.8%
NanoViricides (NNVC) - 66.93M - -15.27% -12.6%
Astellas Pharma (ALPMY) - 28.81B 15.65 -3.96% -1.64%
Aeolus Pharma (AOLS) - 25.85M - -5.71% -19.51%
Health Sciences Group (HESG) - 0.19M - 0 0
Redhill Biopharma (RDHL) - 173.14M - -3.04% 2.3%
Eisai (ESALY) - 16.63B 39.92 -2.76% -6.76%
Loxo Oncology (LOXO) - 1.01B - 3.28% 97.44%
Medicure (MCUJF) - 104.84M 33.48 -5% 90%
Neuroderm (NDRM) - 591.72M - -4.39% 68.26%
Neurobio Tech (NTII) - 0.41M - 0 7.14
Shandong Luoxin (SLUXY) - 223.97M - 0 -28.05
Takeda Pharma (TKPYY) - 32.53B 23.76 -2.96% -12.91%
Ore Holdings (ORXE) - 0.71M - -7.14% 73.33%
Pivotal Therapeutics (PVTTF) - 0.17M - 0 -95
SIGA Technologies (SIGA) - 161.97M - -2.6% 466.04%
Vernalis (VNLPY) - 200.01M - 0 -55.29
Pharmagen (PHRX) - 1.24M - 0 0
Aoxing Pharma (AXN) - 33.53M 11.08 3.5% -38.47%
Aerie Pharma (AERI) - 1.37B - -4.35% 112.83%
Can-Fite Biopharma (CANF) - 29.14M - -12.71% -4.63%
Evotec (EVTCY) - 1.09B 53.93 -5.84% 117.83%
Nuvo Pharmaceuticals (NRIFF) - 46.74M 23.82 -3.11% -6.9%
Minerva Neurosciences (NERV) - 365.47M - -8.62% 100.76%
Inyx (IYXI) - 0.03M - 0 -75
Miravant Medical Technologies (MRVT) - 0M - 0 0
Cardax (CDXI) - 7.5M - -10% -62.66%
Immunosyn Corp. (IMYN) - 0.03M - N/A N/A
Rock Creek Pharma (RCPIQ) - 0.17M - 0 -99.84
Alseres Pharma (ALSE) - 0.3M - 0 -23.08
Bioasis Technologies (BIOAF) - 36.8M - -3.29% -2.7%
Emisphere Tech (EMIS) - 32.07M - 0.6% -20.63%
Forward Pharma (FWP) - 687.15M - 67.63% 82.23%
NovaBay Pharma (NBY) - 55.24M - -7.59% 14.06%
Indivior (INVVY) - 2.65B - -1.66% 63.79%
IsoRay (ISR) - 34.65M - -5% -16.4%
Omni Bio Pharmaceuticals (OMBP) - 1M - -21.74% -40%
Polydex Pharma (POLXF) - 5.44M 8.43 0 9.26
Synergy Pharma (SGYP) - 1.15B - -12.18% 49.62%
Fennec Pharma (FENCF) - 26.6M - -4.41% 30%
Puramed Bioscience (PMBS) - 0.02M - 0 0
Applied Neurosolutions (APSN) - 0M - N/A N/A
Ignyta (RXDX) - 206.18M - -4.81% -51.8%
Curaxis Pharma (CURXQ) - 0.05M - 0 0
Radius Health (RDUS) - 1.93B - -1.34% 25.49%
HST Global (HSTC) - 0.22M - 0 50
Otonomy (OTIC) - 464.99M - -9.85% -10.17%
Merck KGAA (MKGAF) - 14.06B 30.56 -1.27% 26.88%
IntelGenx Technologies (IGXT) - 52.8M - -1.29% 78.51%
Tianyin Pharma (TPIY) - 0.29M - 25% -92.31%
Poniard Pharma (PARD) - 0.12M - -42.86 0
Pharmaxis (PXSLY) - 60.13M - 0 -23.51
UCB SA (UCBJF) - 13.03B - 0 -21.44
Vioquest Pharma (VOQP) - 0.04M - 0 -60
CSPC Pharma (CHPTY) - 6.66B 25.78 5.87% 22.95%
Acerus Pharma (TRLPF) - 21.52M 6.67 -3.85% 11.11%
Sage Therapeutics (SAGE) - 1.97B - -3.87% 33.55%
Matinas Biopharma (MTNB) - 116.22M - 11.73% 203.03%
Innovus Pharma (INNV) - 20.16M - -12.86% 357.5%
Integrated Biopharma (INBP) - 5.59M 3.84 0.38% 120.83%
Symbollon Pharma (SYMBA) - 0M - N/A N/A
Novadel Pharma (NVDL) - 1.03M - -27.27 0
Pacifichealth (PHLI) - 0.31M - 0 50
OXIS International (OXIS) - 2.76M - -62.67% -95.58%
Protalex (PRTX) - 28.48M - 0 -77.75
Boston Therapeutics (BTHE) - 2.87M - -2.94% -34%
Ampio Pharma (AMPE) - 52.95M - -6.44% -61.27%
Akebia Therapeutics (AKBA) - 365.23M - -4.02% 22.78%
GelStat (GSAC) - 0.2M - 0 -75
Vertical Health (ONMDQ) - 0.16M - N/A N/A
China Sky One Medical (CSKI) - 1.02M - N/A N/A
Antriabio (ANTB) - 40.95M - 12.63% -17.69%
Lotus Pharma (LTUS) - 0.06M - 0 -66.67
Peak Pharma (PKPH) - 6.27M - -5.75% 203.7%
Skinvisible (SKVI) - 4.89M - 60% 60%
Tibet Pharma (TBET) - 0M - 0 0
Ono Pharma (OPHLF) - 14.98B 25.69 0 -26.5
Futurebiotics (VITK) - 0M - 0 0
Tribute Pharma (TBUFF) - 117.37M - 0.54 0
AXM Pharma (AXMP) - 0.04M - 0 -60
Acusphere (ACUS) - 0.09M - 0 -67.27
Sevion Therapeutics (SVON) - 5.55M - 10.42% 3.92%
Flexion Therapeutics (FLXN) - 575.85M - -3.91% 17.45%
BIOCARDIA INC (BCDA) - 375.09M 42.38 -3.05% 1208.82%
Actinium Pharma (ATNM) - 53.86M - -8.43% -58.96%
CytoDyn (CYDY) - 103.39M - -3.52% -31.48%
Imagenetix (IAGX) - 0.09M - 0 -97.27
Enumeral Biomed (ENUM) - 17.92M - 15.38% -34.78%
Meldex International (MLGGY) - 0.14M - N/A N/A
Tesaro Inc (TSRO) - 8.01B - -6.02% 279.84%
Pharmos (PARS) - 0.73M - 53.85% -47.37%
Uluru (ULUR) - 6.3M - 1.01% -43.18%
Esperion Therapeutics (ESPR) - 251.03M - -7.67% -41.03%
Bohai Pharma (BOPH) - 9.76M - -7.41% 56.25%